Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 42 out of 100. Getting a diagnosis

Topic: Amyloid, tau and blood-test diagnosis

Internal consistency of the ACE-III was strong (McDonald's ω = 0.889). The ACE-III demonstrated superior diagnostic accuracy compared with the MMSE, with optimal cutoffs of 88.5 (sensitivity, 98%; specificity, 92%) for distinguishing controls from MCI and 72.5 (sensitivity, 90%; specificity, 76%) for distinguishing MCI from AD-D. The ACE-III is a reliable and sensitive tool for detecting early cognitive decline in the Polish population. Its superior diagnostic utility compared with the MMSE, particularly in identifying early neurocognitive impairment, supports its use in timely diagnosis and intervention.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Barczak, A., & Krempa-Kowalewska, A. (2026). Validation of the Polish Version of Addenbrooke’s Cognitive Examination III in Mild Cognitive Impairment and Alzheimer’s Disease Dementia. Dementia and Geriatric Cognitive Disorders. https://doi.org/10.1159/000549856

Vancouver

Barczak A, Krempa-Kowalewska A. Validation of the Polish Version of Addenbrooke’s Cognitive Examination III in Mild Cognitive Impairment and Alzheimer’s Disease Dementia. Dementia and Geriatric Cognitive Disorders. 2026. doi:10.1159/000549856. PMID: 41528923.

BibTeX

@article{barczak2026-41528923,
  author  = {Barczak, Anna and Krempa-Kowalewska, Anna},
  title   = {{Validation of the Polish Version of Addenbrooke’s Cognitive Examination III in Mild Cognitive Impairment and Alzheimer’s Disease Dementia}},
  journal = {Dementia and Geriatric Cognitive Disorders},
  year    = {2026},
  doi     = {10.1159/000549856},
  pmid    = {41528923},
  url     = {https://doi.org/10.1159/000549856}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

The Polish version of the ACE-III showed strong internal consistency and better diagnostic accuracy than the MMSE for distinguishing controls from mild cognitive impairment and mild cognitive impairment from Alzheimer's disease dementia. This supports its use in timely diagnosis, but it is a cognitive screening tool and does not treat or prevent dementia.

Study details

How this study scored 42/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 3 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 4 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record left out, no data; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. 40 of the 96 points it could be judged on, which is 42 of 100. Total 42 of 100.40 of the 96 points we could judge = 42 of 100

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 40 of the 96 points we could judge it on, which is 42 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Dementia and Geriatric Cognitive Disorders)
Journal's citation record 1 / 4 Dementia and Geriatric Cognitive Disorders: journal h-index 149 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 3 / 4 1,265 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 3 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.5 citations a year over 2 year(s) since 2026
Impact for its field and year 4 / 6 Cited 14.2× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 3 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Anna Krempa-Kowalewska holds only 9 work(s), too few to judge a track record — left out of this score
Institution's track record 0 / 3 Polish Academy of Sciences: institution h-index 593 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41528923)
Free to read 0 / 2 Behind a paywall — scores zero
Points 40 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 40 of the 96 points we could judge it on is 42 out of 100.
Total 42 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Related studies in Getting a diagnosis

Also tagged “mini-mental”

840 studies in the library carry the topic tag “mini-mental”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Getting a diagnosis

See all studies in Getting a diagnosis →